2016
After surviving cancer, what about late life effects of the cure?
Publication
Publication
The widely used chemotherapeutic cisplatin causes ototoxicity as late-term side effect. In this issue, Benkafadar et al () decipher the mechanism of cisplatin-induced ototoxicity and provide evidence that transient inhibition of p53 ameliorates ototoxicity without influencing chemotherapeutic efficacy. These findings may open exciting perspectives for reducing (late-term) side effects of cancer treatment.
| Additional Metadata | |
|---|---|
| doi.org/10.15252/emmm.201607062, hdl.handle.net/1765/108032 | |
| EMBO Molecular Medicine | |
| Organisation | Department of Molecular Genetics |
|
Nonnekens, J., & Hoeijmakers, J. (2016). After surviving cancer, what about late life effects of the cure?. EMBO Molecular Medicine. doi:10.15252/emmm.201607062 |
|
